Clinical Trials Logo
  1. Home
  2. Infant, Premature
  3. NCT03333174

Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3

Infant,Premature Clinical Trial

Official title:
Prematurity-Related Ventilatory Control (PRE-VENT): Role in Respiratory Outcomes Clinical Research Centers (CRC) - Specific Aim 3

Clinical Trial Summary

To determine if servo-controlled oxygen environment is associated with reduction in (a) bradycardia events, (b) hypoxemic time, (c) bradycardia time, (d) apneic episodes

Clinical Trial Description

This study will enroll the subset of infants enrolled in the main study (PreVENT Aim 1; 401-1000g at birth and/or 22w 0d-28w 6d; enrolled at <1 week postnatal age; eligible for full care and surviving beyond 24 hours, with informed consent; and with no major malformations) who are receiving oxygen supplementation at 32w and 36w postmenstrual age (PMA), and are not judged too unstable by the Attending neonatologist. For infants on oxygen supplementation at 32w PMA, the investigators will use data from the 96 hours of intensive multiparametric physiologic monitoring at 32w PMA. For infants on oxygen supplementation at 36w PMA, we will use the 96 hours of intensive multiparametric physiologic monitoring at 36w PMA as well as data from the sleep study. The first 24 hours of data collection will be the baseline data. Over the next 72 hours, the investigators will evaluate 3 interventions in a cross-over manner with the initial intervention (cannula or oxygen environment) randomly assigned: Intervention 1 (24-48h of data), Intervention 2 (48-72h of data) and Intervention 3 (72-96h of data). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03333174
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Completed
Phase N/A
Start date April 9, 2018
Completion date July 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03445689 - Oxygenation Instability and Maturation of Control of Breathing in Premature Infants
Completed NCT03245723 - Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI) N/A
Active, not recruiting NCT03575897 - Serial Assessment of Body Fat Accrual in Very Preterm Infants N/A
Completed NCT03082313 - Movement-based Infant Intervention N/A
Completed NCT03696758 - Improving Right Ventricular Function in Young Adults Born Preterm Phase 2
Withdrawn NCT01569633 - Use of Prokinetics in Early Enteral Feeding in Preterm Infants N/A
Terminated NCT03532555 - Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia N/A
Completed NCT03230032 - Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy N/A
Recruiting NCT03693287 - Personalized vs Standardized PN for Preterm Infants >1250g Phase 4
Terminated NCT03542812 - L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia Early Phase 1
Completed NCT03434743 - Non-nutritive Sucking and Breastfeeding in Preterm Infants N/A
Active, not recruiting NCT03168516 - Effects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants Phase 3
Completed NCT03357458 - Parent-child Interactions, Child Developmental Health, and Health System Costs at 6 Months Corrected Age N/A
Recruiting NCT03521063 - Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. Phase 4
Recruiting NCT03501485 - Impact of Protein Supplementation to Mother Milk on Resting Energy Expenditure (REE) in Growing Healthy Preterm Infants.
Completed NCT03280381 - Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding N/A
Completed NCT03586856 - Comparison of Leakage With Nasal Prongs and Nasal Mask Interface in Newborns Receiving CPAP Treatment N/A
Completed NCT03333161 - Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 2 N/A
Active, not recruiting NCT03558737 - Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants N/A